Teva responds to Mylan backlash with planned launch of generic EpiPen

09. September 2016 Health 0

Mylan Pharmaceutical may be getting some competition for its EpiPen, as Israel-based Teva Pharmaceutical Industries announced Friday that it hopes to launch its own generic version of the device by 2018 in the U.S.